Concepedia

Peter Vermaelen

PV

Statistics

Publications

16

Citations

936

H-Index

15

Active since

2004

Affiliations

KU Leuven(Current)

University of Pennsylvania

Rega Institute for Medical Research

Peter Vermaelen is an author at KU Leuven specializing in medicine, pharmacology, and engineering.

Top concepts

Publications per year

2004–2012

16

Publications

16

Disparity Between In Vivo EGFR Expression and <sup>89</sup>Zr-Labeled Cetuximab Uptake Assessed with PET

Hugo J.W.L. Aerts, Ludwig J. Dubois, Lars R. Perk et al. · Journal of Nuclear Medicine · 2008 · 194 citations · Full text

Evaluation of hypoxia in an experimental rat tumour model by [18F]Fluoromisonidazole PET and immunohistochemistry

Ludwig J. Dubois, Willy Landuyt, Karin Haustermans et al. · British Journal of Cancer · 2004 · 110 citations · Full text

Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.

Cindy Casteels, Peter Vermaelen, Johan Nuyts et al. · PubMed · 2006 · 110 citations

Synthesis and Evaluation of <sup>18</sup>F-Labeled 2-Phenylbenzothiazoles as Positron Emission Tomography Imaging Agents for Amyloid Plaques in Alzheimer’s Disease

Kim Serdons, Christelle Terwinghe, Peter Vermaelen et al. · Journal of Medicinal Chemistry · 2009 · 93 citations · Full text

, , +17

A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal

Giuseppe Floris, Agnieszka Woźniak, Raf Sciot et al. · Clinical Cancer Research · 2012 · 68 citations · Full text

1–5 of 16